Advertisement
One-year results from national database confirm enduring benefits
Q&A with Dr. Andrew Russman, Medical Director of our Comprehensive Stroke Center
SARS-CoV-2’s potential for neuroinvasion and primary emerging neurologic features
In general, interrupting therapy is not advised, and patients should remain in contact with their provider teams
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
From B-PROUD to EXTEND-IA TNK to a novel TMS delivery method
For this health crisis, a consortium is stronger than the sum of its parts
Recommendations revisited in wake of a surge in disease-modifying therapies
Local population, deep expertise portend a center with high impact
What we've contributed, gained and learned through the partnership
Disappointing performance for the dual serotonin receptor antagonist
Advertisement
Advertisement